Literature DB >> 23311800

Current glycaemic control has no impact on the advancement of diabetic neuropathy.

Piotr Dziemidok1, Grzegorz Szcześniak, Ewa Kostrzewa-Zabłocka, Piotr Paprzycki, Anna Korzon-Burakowska.   

Abstract

UNLABELLED: The aim of the study was to assess the association between glycemic control understanding as a glycated haemoglobin level and indices of diabetic neuropathy.
METHODS: We evaluated 204 patients with diabetes (type 1 - 29; type 2 - 175). Glycated haemoglobin was determined using The Diabetes Control and Complications Trial/ National Glycohemoglobin Standardization Program method. Evaluation of complaints from the lower extremities was based on the Neuropathy Syndrome Total Score questionnaire. We used a mono lament for evaluation of touch sensation (Semmes-Weinstein 5.07-10 g), a 128 Hz calibrated tune-fork for the vibration perception test, Tip-Therm to assess temperature sensation.
RESULTS: The mean glycated haemoglobin level was assessed on 8.53±1.87%. The mean Neuropathy Syndrome Total Score: 11.45±6.37. Decreased sensation of touch on both sides was determined in 30% of cases, decreased sensation of temperature in 59% and decreased sensation of vibration in 30%. For Neuropathy Syndrome Total Score and glycated haemoglobin the Pearson's correlation test was 0.00910 (p≈0.99), Spearman's rank correlation test was 0.00523 (p≈0.95). Persons with sensation deficits and neuropathy symptoms had not significantly higher (Neuropathy Syndrome Total Score, temperature sensation disturbances) and not significantly lower (vibration and touch) glycated haemoglobin level compared to patients without neuropathy.
CONCLUSION: There is no correlation between prevalence and advancement of sensorial neuropathy and current diabetes control in patients with long-term established diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23311800

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  5 in total

1.  Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial.

Authors:  Geraldine F Clough; Keith G McCormick; Eleonora Scorletti; Lokpal Bhatia; Philip C Calder; Michael J Griffin; Christopher D Byrne
Journal:  Diabetologia       Date:  2016-04-22       Impact factor: 10.122

2.  Pattern and microbiological characteristics of diabetic foot ulcers in a Nigerian tertiary hospital.

Authors:  Obumneme Anyim; Christian Okafor; Ekenechukwu Young; Ijeoma Obumneme-Anyim; Chidimma Nwatu
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

Review 3.  Glycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy.

Authors:  Giulia Casadei; Marta Filippini; Lorenzo Brognara
Journal:  Diseases       Date:  2021-02-22

4.  Impact of glycemic control on colonoscopy outcomes: bowel preparation and polyp detection.

Authors:  Manhal Izzy; Kinesh Changela; Dhuha Alhankawi; Nami Safai Haeri; Sulay Shah; Ghalib Jibara; Sury Anand; Shashideep Singhal
Journal:  Ann Gastroenterol       Date:  2016-03-03

5.  The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan.

Authors:  Nahla Khawaja; Jawad Abu-Shennar; Mohammed Saleh; Said S Dahbour; Yousef S Khader; Kamel M Ajlouni
Journal:  Diabetol Metab Syndr       Date:  2018-02-21       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.